JP2009537176A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009537176A5 JP2009537176A5 JP2009512060A JP2009512060A JP2009537176A5 JP 2009537176 A5 JP2009537176 A5 JP 2009537176A5 JP 2009512060 A JP2009512060 A JP 2009512060A JP 2009512060 A JP2009512060 A JP 2009512060A JP 2009537176 A5 JP2009537176 A5 JP 2009537176A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- cells
- subpopulation
- antibody
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000427 antigen Substances 0.000 claims 41
- 102000036639 antigens Human genes 0.000 claims 41
- 108091007433 antigens Proteins 0.000 claims 41
- 238000000034 method Methods 0.000 claims 39
- 210000003719 b-lymphocyte Anatomy 0.000 claims 24
- 210000004027 cell Anatomy 0.000 claims 11
- 210000000628 antibody-producing cell Anatomy 0.000 claims 10
- 230000006698 induction Effects 0.000 claims 6
- 230000001629 suppression Effects 0.000 claims 6
- 239000011159 matrix material Substances 0.000 claims 5
- 239000007787 solid Substances 0.000 claims 5
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims 3
- 239000011324 bead Substances 0.000 claims 3
- 241000282414 Homo sapiens Species 0.000 claims 2
- 241000283973 Oryctolagus cuniculus Species 0.000 claims 2
- 210000001744 T-lymphocyte Anatomy 0.000 claims 2
- 230000008484 agonism Effects 0.000 claims 2
- 230000008485 antagonism Effects 0.000 claims 2
- 230000008236 biological pathway Effects 0.000 claims 2
- 210000002798 bone marrow cell Anatomy 0.000 claims 2
- 230000006037 cell lysis Effects 0.000 claims 2
- 210000001165 lymph node Anatomy 0.000 claims 2
- 239000002609 medium Substances 0.000 claims 2
- 102000039446 nucleic acids Human genes 0.000 claims 2
- 108020004707 nucleic acids Proteins 0.000 claims 2
- 150000007523 nucleic acids Chemical class 0.000 claims 2
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 claims 2
- 230000035755 proliferation Effects 0.000 claims 2
- 210000000952 spleen Anatomy 0.000 claims 2
- 241000894006 Bacteria Species 0.000 claims 1
- 241000700199 Cavia porcellus Species 0.000 claims 1
- 102000006395 Globulins Human genes 0.000 claims 1
- 108010044091 Globulins Proteins 0.000 claims 1
- 241000238631 Hexapoda Species 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 241000699666 Mus <mouse, genus> Species 0.000 claims 1
- 241000235648 Pichia Species 0.000 claims 1
- 241000700159 Rattus Species 0.000 claims 1
- 241000283984 Rodentia Species 0.000 claims 1
- 238000001261 affinity purification Methods 0.000 claims 1
- 239000003636 conditioned culture medium Substances 0.000 claims 1
- 230000001143 conditioned effect Effects 0.000 claims 1
- 238000012258 culturing Methods 0.000 claims 1
- 239000012634 fragment Substances 0.000 claims 1
- 210000004962 mammalian cell Anatomy 0.000 claims 1
- 229920001184 polypeptide Polymers 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
- 108090000765 processed proteins & peptides Proteins 0.000 claims 1
- 238000012163 sequencing technique Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US80141206P | 2006-05-19 | 2006-05-19 | |
| US60/801,412 | 2006-05-19 | ||
| PCT/US2007/011980 WO2008045140A1 (en) | 2006-05-19 | 2007-05-21 | Culture method for obtaining a clonal population of antigen-specific b cells |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009537176A JP2009537176A (ja) | 2009-10-29 |
| JP2009537176A5 true JP2009537176A5 (enExample) | 2010-07-08 |
| JP5607357B2 JP5607357B2 (ja) | 2014-10-15 |
Family
ID=39283142
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009512060A Expired - Fee Related JP5607357B2 (ja) | 2006-05-19 | 2007-05-21 | 抗原特異的ｂ細胞のクローン集団を獲得するための培養方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US20070269868A1 (enExample) |
| EP (1) | EP2021463B1 (enExample) |
| JP (1) | JP5607357B2 (enExample) |
| CN (1) | CN101600793B (enExample) |
| AU (1) | AU2007307324B2 (enExample) |
| CA (1) | CA2652392C (enExample) |
| DK (1) | DK2021463T3 (enExample) |
| IL (1) | IL195285A (enExample) |
| MX (1) | MX2008014692A (enExample) |
| NO (1) | NO20084835L (enExample) |
| NZ (1) | NZ572807A (enExample) |
| WO (1) | WO2008045140A1 (enExample) |
Families Citing this family (68)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8178101B2 (en) | 2007-05-21 | 2012-05-15 | Alderbio Holdings Inc. | Use of anti-IL-6 antibodies having specific binding properties to treat cachexia |
| US8252286B2 (en) | 2007-05-21 | 2012-08-28 | Alderbio Holdings Llc | Antagonists of IL-6 to prevent or treat thrombosis |
| US7906117B2 (en) | 2007-05-21 | 2011-03-15 | Alderbio Holdings Llc | Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or fever |
| CN101754772B (zh) | 2007-05-21 | 2015-08-19 | 奥尔德生物控股有限责任公司 | 针对il-6的抗体及其用途 |
| US9701747B2 (en) | 2007-05-21 | 2017-07-11 | Alderbio Holdings Llc | Method of improving patient survivability and quality of life by anti-IL-6 antibody administration |
| US8062864B2 (en) | 2007-05-21 | 2011-11-22 | Alderbio Holdings Llc | Nucleic acids encoding antibodies to IL-6, and recombinant production of anti-IL-6 antibodies |
| US8404235B2 (en) | 2007-05-21 | 2013-03-26 | Alderbio Holdings Llc | Antagonists of IL-6 to raise albumin and/or lower CRP |
| US9452227B2 (en) | 2008-11-25 | 2016-09-27 | Alderbio Holdings Llc | Methods of treating or diagnosing conditions associated with elevated IL-6 using anti-IL-6 antibodies or fragments |
| US8323649B2 (en) | 2008-11-25 | 2012-12-04 | Alderbio Holdings Llc | Antibodies to IL-6 and use thereof |
| US9212223B2 (en) | 2008-11-25 | 2015-12-15 | Alderbio Holdings Llc | Antagonists of IL-6 to prevent or treat thrombosis |
| US8992920B2 (en) | 2008-11-25 | 2015-03-31 | Alderbio Holdings Llc | Anti-IL-6 antibodies for the treatment of arthritis |
| US8420089B2 (en) | 2008-11-25 | 2013-04-16 | Alderbio Holdings Llc | Antagonists of IL-6 to raise albumin and/or lower CRP |
| US8337847B2 (en) | 2008-11-25 | 2012-12-25 | Alderbio Holdings Llc | Methods of treating anemia using anti-IL-6 antibodies |
| MX2011005411A (es) * | 2008-11-25 | 2011-06-16 | Alder Biopharmaceuticals Inc | Anticuerpos de il-6 y uso de los mismos. |
| US9079942B2 (en) * | 2009-02-09 | 2015-07-14 | Epitomics, Inc. | CDR-anchored amplification method |
| US20100317539A1 (en) * | 2009-06-12 | 2010-12-16 | Guo-Liang Yu | Library of Engineered-Antibody Producing Cells |
| PT3023438T (pt) | 2009-09-03 | 2020-05-08 | Merck Sharp & Dohme | Anticorpos anti-gitr |
| US8293483B2 (en) | 2009-09-11 | 2012-10-23 | Epitomics, Inc. | Method for identifying lineage-related antibodies |
| US9775921B2 (en) | 2009-11-24 | 2017-10-03 | Alderbio Holdings Llc | Subcutaneously administrable composition containing anti-IL-6 antibody |
| EP2504032A4 (en) | 2009-11-24 | 2013-06-19 | Alderbio Holdings Llc | IL-6 ANTAGONISTS FOR PREVENTING OR TREATING THROMBOSIS |
| TWI667257B (zh) | 2010-03-30 | 2019-08-01 | 中外製藥股份有限公司 | 促進抗原消失之具有經修飾的ＦｃＲｎ親和力之抗體 |
| ES2434256T3 (es) * | 2010-05-28 | 2013-12-16 | F. Hoffmann-La Roche Ag | Método de cultivo de células B individuales y producción de anticuerpos específicos |
| CA2818814A1 (en) | 2010-11-23 | 2012-05-31 | Alder Biopharmaceuticals, Inc. | Anti-il-6 antibodies for the treatment of anemia |
| NZ611076A (en) | 2010-12-01 | 2015-09-25 | Alderbio Holdings Llc | Anti-ngf compositions and use thereof |
| WO2012133572A1 (ja) | 2011-03-30 | 2012-10-04 | 国立大学法人富山大学 | 形質細胞または形質芽細胞の選択方法、目的抗原特異的な抗体の製造方法、新規モノクローナル抗体 |
| SG10201604040PA (en) | 2011-05-20 | 2016-07-28 | Alderbio Holdings Llc | Anti-cgrp compositions and use thereof |
| NZ732875A (en) | 2011-05-20 | 2022-08-26 | H Lundbeck As | Use of anti-cgrp or anti-cgrp-r antibodies or antibody fragments to treat or prevent chronic and acute forms of diarrhea |
| RS66303B1 (sr) | 2011-05-20 | 2025-01-31 | H Lundbeck As | Upotreba anti-cgrp antitela i fragmenata antitela za sprečavanje ili inhibiranje fotofobije ili odbojnosti prema svetlu kod subjekata kojima je to potrebno, naročito kod subjekata koji pate od migrene |
| WO2013000982A1 (en) * | 2011-06-27 | 2013-01-03 | Vivalis | Method for screening cells |
| EP2761015A4 (en) * | 2011-09-28 | 2015-09-02 | Cb Biotechnologies Inc | IDENTIFICATION OF ANTIGEN-SPECIFIC ADAPTIVE IMMUNE REACTIONS BY ARM-PCR AND HIGH-BY-STEP SEQUENCING |
| KR102069394B1 (ko) | 2011-11-23 | 2020-01-22 | 에프. 호프만-라 로슈 아게 | Ｃｄ40ｌ 발현 포유류 세포 및 그의 용도 |
| JP2015500655A (ja) | 2011-12-21 | 2015-01-08 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | 同起源の抗体可変領域遺伝子セグメントをクローニングおよび発現させるための迅速な方法 |
| EP2727943A1 (en) | 2012-11-05 | 2014-05-07 | MAB Discovery GmbH | Trispecific antibodies against human EGFR, HER2 and HER3 |
| EP2914629A1 (en) | 2012-11-05 | 2015-09-09 | MAB Discovery GmbH | Method for the production of multispecific antibodies |
| EP2727942A1 (en) | 2012-11-05 | 2014-05-07 | MAB Discovery GmbH | Bispecific antibodies against human EGFR, HER2, and HER3 |
| EP2727941A1 (en) | 2012-11-05 | 2014-05-07 | MAB Discovery GmbH | Method for the production of multispecific antibodies |
| EP2917238A1 (en) | 2012-11-08 | 2015-09-16 | Eleven Biotherapeutics, Inc. | Il-6 antagonists and uses thereof |
| AU2013344992A1 (en) * | 2012-11-13 | 2015-05-14 | Genentech, Inc. | Enrichment of antigen-specific plasmablasts |
| JP2016506974A (ja) * | 2013-02-15 | 2016-03-07 | エスバテック − ア ノバルティスカンパニー エルエルシー | Ｃｄｒグラフトのためのアクセプターフレームワーク |
| KR20150140685A (ko) * | 2013-03-14 | 2015-12-16 | 앨더 바이오파마슈티컬즈, 인코포레이티드 | Hgf에 대한 항체 및 이를 포함하는 조성물 |
| ES2834113T3 (es) | 2013-03-15 | 2021-06-16 | H Lundbeck As | Purificación de anticuerpos y monitorización de la pureza |
| US20140287952A1 (en) * | 2013-03-15 | 2014-09-25 | Alderbio Holdings Llc | Protocol for identifying and isolating antigen-specific b cells and producing antibodies to desired antigens |
| US10138294B2 (en) | 2013-03-15 | 2018-11-27 | Alderbio Holdings Llc | Temperature shift for high yield expression of polypeptides in yeast and other transformed cells |
| US20160075766A1 (en) | 2013-05-21 | 2016-03-17 | Roche Diagnostics Operations, Inc. | Method for producing antibodies using ovine b-cells and uses thereof |
| CN104232577B (zh) * | 2013-06-20 | 2017-12-01 | 中国人民解放军军事医学科学院基础医学研究所 | 一种获得自身反应性b细胞的方法 |
| WO2015003122A2 (en) | 2013-07-03 | 2015-01-08 | Alder Biopharmaceuticals, Inc. | Regulation of glucose metabolism using anti-cgrp antibodies |
| US11142571B2 (en) | 2014-11-07 | 2021-10-12 | Sesen Bio, Inc. | IL-6 antibodies |
| US10047157B2 (en) | 2014-12-19 | 2018-08-14 | Alder Biopharmaceuticals, Inc. | Humanized anti-ACTH antibodies and use thereof |
| EP3271393A4 (en) * | 2015-03-18 | 2018-10-31 | Epitomics, Inc. | High throughput monoclonal antibody generation by b cell panning and proliferation |
| EP3305325B1 (en) | 2015-06-04 | 2025-07-30 | National Center of Neurology and Psychiatry | Mental illness therapeutic agent having il-6 inhibitor as active ingredient |
| CN108026172B (zh) | 2015-06-26 | 2022-04-29 | 赛诺菲生物技术公司 | 单克隆抗il-1racp抗体 |
| EP3419599A4 (en) | 2016-02-23 | 2019-09-11 | Sesen Bio, Inc. | IL-6 ANTAGONIST FORMULATIONS AND USE THEREOF |
| JP7026634B2 (ja) | 2016-03-30 | 2022-02-28 | エフ．ホフマン－ラ ロシュ アーゲー | Ｂ細胞培養法 |
| CA3020839A1 (en) | 2016-04-15 | 2017-10-19 | Alder Biopharmaceuticals, Inc. | Anti-pacap antibodies and uses thereof |
| EP3241845A1 (en) | 2016-05-06 | 2017-11-08 | MAB Discovery GmbH | Humanized anti-il-1r3 antibodies |
| CN106350485B (zh) * | 2016-08-24 | 2020-02-21 | 杭州百凌生物科技有限公司 | 一种快速高效分离单个抗原特异性b细胞的方法 |
| JP6916884B2 (ja) | 2017-01-02 | 2021-08-11 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | Ｂ細胞培養法 |
| EP3401332A1 (en) | 2017-05-08 | 2018-11-14 | MAB Discovery GmbH | Anti-il-1r3 antibodies for use in inflammatory conditions |
| EP3625332B1 (en) | 2017-05-19 | 2022-02-02 | F. Hoffmann-La Roche AG | Method for the production of thymocyte supernatant |
| US11125757B2 (en) * | 2017-05-26 | 2021-09-21 | Emory University | Methods of culturing and characterizing antibody secreting cells |
| CN111417719B (zh) | 2017-11-30 | 2023-08-29 | 豪夫迈·罗氏有限公司 | B细胞培养方法 |
| JP2021525070A (ja) * | 2018-05-18 | 2021-09-24 | チャン ザッカーバーグ バイオハブ， インコーポレイテッド | ヒト由来のアレルゲン特異的抗体を単離する方法およびその使用 |
| EP4004044A1 (en) | 2019-07-24 | 2022-06-01 | H. Lundbeck A/S | Anti-mglur5 antibodies and uses thereof |
| JP2023106635A (ja) | 2020-04-17 | 2023-08-02 | 中外製薬株式会社 | 二重特異性抗原結合分子ならびに、それに関連する組成物、組成物の製造のための使用、キット、および方法 |
| WO2022004620A1 (ja) * | 2020-06-29 | 2022-01-06 | 株式会社Npt | 抗原特異的抗体産生細胞を含む組成物の製造方法、ワクチン組成物の製造方法、細胞分離キットおよびワクチン組成物 |
| JP2024509971A (ja) | 2021-03-11 | 2024-03-05 | アイジェニックス， インコーポレイテッド | アレルギー応答を予測するための方法およびシステム |
| US20240228595A1 (en) * | 2021-05-11 | 2024-07-11 | Yale University | Methods for Monoclonal Antibody Generation |
| EP4590704A1 (en) | 2022-09-21 | 2025-07-30 | Sanofi Biotechnology | Humanized anti-il-1r3 antibody and methods of use |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6657103B1 (en) * | 1990-01-12 | 2003-12-02 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| AU7796291A (en) * | 1990-05-04 | 1991-11-27 | Baxter Diagnostics Inc. | High affinity antibodies to small peptides |
| CA2090126C (en) | 1990-08-02 | 2002-10-22 | John W. Schrader | Methods for the production of proteins with a desired function |
| ZA919299B (en) * | 1990-11-26 | 1992-08-26 | Akzo Nv | Method for the production of antibodies |
| US6277969B1 (en) * | 1991-03-18 | 2001-08-21 | New York University | Anti-TNF antibodies and peptides of human tumor necrosis factor |
| US5256542A (en) * | 1992-03-09 | 1993-10-26 | Tanox Biosystems, Inc. | Selecting low frequency antigen-specific single B lymphocytes with correction for background noise |
| US6972125B2 (en) * | 1999-02-12 | 2005-12-06 | Genetics Institute, Llc | Humanized immunoglobulin reactive with B7-2 and methods of treatment therewith |
| RU2318829C2 (ru) * | 2001-11-14 | 2008-03-10 | Сентокор, Инк. | Антитела против il-6, композиции, способы и применение |
| US20040185040A1 (en) * | 2001-11-21 | 2004-09-23 | Celltech R & D Limited | Modulating immune responses |
| US8188231B2 (en) * | 2002-09-27 | 2012-05-29 | Xencor, Inc. | Optimized FC variants |
| US7993864B2 (en) | 2002-12-03 | 2011-08-09 | Ucb Pharma S.A. | Assay for identifying antibody producing cells |
| GB0312481D0 (en) | 2003-05-30 | 2003-07-09 | Celltech R&D Ltd | Antibodies |
| US20050033031A1 (en) * | 2003-08-07 | 2005-02-10 | Couto Fernando Jose Rebelo Do | Methods for humanizing rabbit monoclonal antibodies |
| US20060263353A1 (en) | 2003-08-20 | 2006-11-23 | Lawson Alastair D G | Methods for obtaining antibodies |
| EP1658498A1 (en) | 2003-08-20 | 2006-05-24 | Celltech R & D Limited | Methods for obtaining antibodies |
| CN1871259A (zh) * | 2003-08-22 | 2006-11-29 | 比奥根艾迪克Ma公司 | 具有改变的效应物功能的经改进的抗体和制备它的方法 |
| WO2005020924A2 (en) * | 2003-08-29 | 2005-03-10 | Centocor, Inc. | A rapid way to obtain high expression clones of mammalian cells using a methylcellulose and immunoprecipitation screening method |
| ES2393555T3 (es) * | 2003-10-22 | 2012-12-26 | Keck Graduate Institute | Métodos para la síntesis de polipéptidos hetero-multiméricos en levaduras usando una estrategia de apareamiento haploide. |
| GB0412973D0 (en) | 2004-06-10 | 2004-07-14 | Celltech R&D Ltd | Identification of antibody producing cells |
| US20060051348A1 (en) * | 2004-09-09 | 2006-03-09 | Jorn Gorlach | Method of producing a plurality of isolated antibodies to a plurality of cognate antigens |
| CN101048426A (zh) * | 2004-10-22 | 2007-10-03 | 金克克国际有限公司 | 分离人抗体 |
| US7462697B2 (en) * | 2004-11-08 | 2008-12-09 | Epitomics, Inc. | Methods for antibody engineering |
| GB0425972D0 (en) | 2004-11-25 | 2004-12-29 | Celltech R&D Ltd | Biological products |
| PA8672101A1 (es) * | 2005-04-29 | 2006-12-07 | Centocor Inc | Anticuerpos anti-il-6, composiciones, métodos y usos |
| WO2007038746A2 (en) * | 2005-09-28 | 2007-04-05 | The University Of Chicago | Versatile vectors for expression of foreign proteins in photosynthetic bacteria |
-
2007
- 2007-05-21 CN CN200780027028.2A patent/CN101600793B/zh not_active Expired - Fee Related
- 2007-05-21 MX MX2008014692A patent/MX2008014692A/es active IP Right Grant
- 2007-05-21 WO PCT/US2007/011980 patent/WO2008045140A1/en not_active Ceased
- 2007-05-21 DK DK07861311.4T patent/DK2021463T3/en active
- 2007-05-21 JP JP2009512060A patent/JP5607357B2/ja not_active Expired - Fee Related
- 2007-05-21 EP EP07861311.4A patent/EP2021463B1/en not_active Revoked
- 2007-05-21 NZ NZ572807A patent/NZ572807A/en not_active IP Right Cessation
- 2007-05-21 US US11/802,235 patent/US20070269868A1/en not_active Abandoned
- 2007-05-21 CA CA2652392A patent/CA2652392C/en not_active Expired - Fee Related
- 2007-05-21 AU AU2007307324A patent/AU2007307324B2/en not_active Ceased
-
2008
- 2008-11-13 IL IL195285A patent/IL195285A/en active IP Right Grant
- 2008-11-18 NO NO20084835A patent/NO20084835L/no unknown
-
2011
- 2011-08-08 US US13/204,915 patent/US20120141982A1/en not_active Abandoned
-
2013
- 2013-04-12 US US13/861,518 patent/US20130316353A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Gregoire et al. | Viral infection engenders bona fide and bystander subsets of lung-resident memory B cells through a permissive mechanism | |
| Ferreira-Gomes et al. | SARS-CoV-2 in severe COVID-19 induces a TGF-β-dominated chronic immune response that does not target itself | |
| Zwijnenburg et al. | Graded expression of the chemokine receptor CX3CR1 marks differentiation states of human and murine T cells and enables cross-species interpretation | |
| JP2016512044A5 (enExample) | ||
| JP2012510618A5 (enExample) | ||
| JP2015506699A5 (enExample) | ||
| JP2013509878A5 (enExample) | ||
| EP3405788A1 (en) | Multifunctional beads and methods of use for capturing target cells | |
| Li et al. | Single cell RNA-sequencing delineates CD8+ tissue resident memory T cells maintaining rejection in liver transplantation | |
| JP2009531694A5 (enExample) | ||
| AU2014232225A1 (en) | Protocol for identifying and isolating antigen-specific B cells and producing antibodies to desired antigens | |
| CA2564834C (en) | Modified elispot assay for detecting multiple analytes at distinct locations within a well | |
| Matsunaga et al. | Fully automated immunoassay for detection of prostate-specific antigen using nano-magnetic beads and micro-polystyrene bead composites,‘Beads on Beads’ | |
| JP2011102805A5 (enExample) | ||
| CN110716053A (zh) | 检测群体反应性抗体的新方法 | |
| JP2023530600A5 (enExample) | ||
| Ferreira-Gomes et al. | In severe COVID-19, SARS-CoV-2 induces a chronic, TGF-β-dominated adaptive immune response | |
| Kitano et al. | HepG2-based designer cells with heat-inducible enhanced liver functions | |
| Shadpour et al. | Enrichment and expansion of cells using antibody‐coated micropallet arrays | |
| Ehlers et al. | Comparison of Two Strategies to Generate Antigen-Specific Human Monoclonal Antibodies: Which Method to Choose for Which Purpose? | |
| Manrique-Rincón et al. | Simulating CD8 T cell exhaustion: A comprehensive approach | |
| CN118725110A (zh) | NT-proBNP抗体及其用途 | |
| Pushparaj | Multiple Analyte Profiling (xMAP) technology coupled with functional bioinformatics strategies: potential applications in protein biomarker profiling in autoimmune inflammatory diseases | |
| WO2014096389A1 (en) | Method for identifying antibody producing cells | |
| CN116286834A (zh) | 一种特异性识别sST2蛋白的核酸适配体及其应用 |